论文部分内容阅读
目的总结曲美他嗪在缺血性扩张型心肌病患者心功能改善方面的作用。方法 2007年1月-2009年12月随机将61例患者分为二组,观察组给予常规药物治疗加用曲美他嗪,对照组给予常规治疗,通过心功能及左心室射血分数两个方面来评估治疗效果。结果观察组较对照组显著增加左室射血分数,并能改善患者心功能分级。结论缺血性扩张型心肌病患者可以很好地耐受较长期的曲美他嗪治疗,同时心功能也得到改善。
Objective To summarize the role of trimetazidine in improving cardiac function in patients with ischemic dilated cardiomyopathy. Methods From January 2007 to December 2009, 61 patients were randomly divided into two groups. The observation group was given conventional medical therapy combined with trimetazidine, while the control group was given routine treatment. The cardiac function and left ventricular ejection fraction To assess the effect of treatment. Results Compared with the control group, the observation group significantly increased left ventricular ejection fraction and improved the classification of cardiac function. Conclusions Patients with ischemic dilated cardiomyopathy are well tolerated by longer-acting trimetazidine and their cardiac function is also improved.